Special review articleA meta-analysis investigating the prevalence and moderators of migraines among people with bipolar disorder
Introduction
Migraine is one the oldest ailments known to mankind (Mandal, 2014). Some of the earliest cases of painful headaches were recorded by the ancient Egyptians and date back as far as 1200 B.C. (Karenberg and Leitz, 2001). Much later, in around 400 B.C., Hippocrates referred to the visual disturbances that can precede a migraine such as flashing lights or blurred vision (“aura”) (Breitenfeld et al., 2014). However, the credit for migraine “discovery” was given to Aretaeus of Cappadocia who described in the second century the one sided or unilateral headaches that are typical of migraines as well as the associated vomiting and the windows of time between migraines that are symptom free (Koehler and van de Wiel, 2001). The word “migraine” itself derived from the Latin word “hemicrania” meaning “half” (hemi) “skull” (crania). This term was first used by Galenus of Pergamon to describe the pain felt across one side of the head during a migraine (Isler, 1992). Yet the documentation of “migraine” features, already documented even in course of “mood disturbances”, was not unique to Western cultures, as recorded by the Chinese surgeon Hua Tuo (late Han Dynasty, second century A.D.) who was the first to successfully use acupuncture needles to relieve the “recurrent” migraines complained by the “irritable, moody” and “tyrannical” founder of his kingdom (Fu, 2002). Similarly, the Islamic philospher Avicenna described migraine in his textbook on medicine “El Qanoon fel teb”, a treatise which is also nowadays considered one of the earliest texts on “melancholia and mania” (Omrani et al., 2012), documenting how eating, drinking, sounds and light all worsened the pain felt during a migraine (Abokrysha, 2009), a report that should nowadays appear clinically intriguing also considering that “hyperesthesia” (sensory over-sensitivity) has been recently linked even to anxious, irritable and mood disturbances (Sylvia et al., 2014). Avicenna described how these patients tended to rest alone in a dark room until the attack passed, but it was Abu Bakr Mohamed Ibn Zakariya Râzi who pointed to an association between migraine and hormones when he referred to how such headaches would occur during menopause, after childbirth or during dysmenorrhea (Mandal, 2014), all conditions that would nowadays potentially linked to the broad definition of bipolar spectrum when leading to “maternity blues”, “post-partum depression” or menstrual disturbances (Akiskal and Mallya, 1987, Di Florio et al., 2013, Fornaro and Perugi, 2010). Yet, it was not until the publication of the results from large studies in carried in Zurich (Merikangas et al., 1990) and Detroit (Breslau et al., 1994) that migraine was systematically documented to be more frequent in mood disorder patients, including bipolar disorder (BD) cases, than in controls.
According to the International Classification of Headache Disorders, 2nd edition (ICHD-2), migraine refers to different phenotypes having in common a low threshold to the development of headache among migraineurs, usually being characterized for a recurring pattern, frequent free-interval, and usually provoked by stereotyped triggers (Headache Classification Subcommittee of the International Headache Society, 2004). Nonetheless, while a conclusive definition of migraine remains elusive, especially due to the heterogeneity of some of the frequently associated neurological and psychiatric comorbidities, a three-fold increase in migraine prevalence in patients with BD has been ascertained (Merikangas et al., 1993), as outlined by a recent systematic review about the prevalence of migraine comorbidity among people with BD (Fornaro et al., 2015). This latter systematic review, first of its kind at writing time, whilst helpful, updated and informative, did not undertake a meta-analysis, nor was there any attempt to stratify the results according to diagnosis (BD-I vs. BD-II), setting or location. Information about how the prevalence of migraine may be influenced according to the classification of BD, geographical location and the criteria used to define a migraine are nonetheless clinically relevant, and conducting meta-analyses offers the potential to provide the most accurate effect size of an actual phenomenon and enable researchers to make wider conclusions than considering individual studies in isolation. Given the burden of migraine among people with BD, there is a need to better understand the prevalence and moderators of migraine. Therefore, to the best of our knowledge, we set out to conduct the first meta-analysis to investigate the prevalence and moderators of migraine comorbidity among people with BD.
Section snippets
Material and methods
The present meta-analysis adhered to the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines (Stroup et al., 2000). The current paper followed the inclusion and exclusion criteria already adopted for our recent Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) systematic review (Fornaro et al., 2015), but extended the inclusion criteria to account also for contributes indexed in PubMed since inception. In addition, searches were updated on all
Study selection
The search in PubMed generated 134 papers, and 595 results in Scopus. Thirteen additional results were obtained through search either in Cochrane (n=7), PsycLit, PsycInfo or reference textbooks/manual search. Refer to Fig. 1 for a synthetic flow chart of the multi-step selection procedure which allowed to retain 14 final original studies accounted in our quantitative analysis.
Included study and participant characteristics
With the sole exception of three retrospective studies (Holland et al., 2011, Munoli et al., 2014, Saunders et al., 2014
Discussion
The current meta-analysis is to our knowledge a first and established that overall approximately one third of people with BD are affected by comorbid migraine (34.8%, 955% CI=25.54–44.69, n=3976). Of particular interest, we have established that higher prevalence of migraine exists among people with BD-II (54%) vs. those with BD-I (32.7%, p<0.0001). Interestingly, we also established for the first time that the prevalence of migraine is substantially higher in studies utilizing recognized
Role of funding source
The authors have no funding source to disclose in conjunction with the present work.
Conflict of interest
The authors have no conflict of interest, neither financial support to disclose in conjunction with the present work.
Acknowledgments
None to state.
References (52)
- et al.
Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review
J. Affect. Disord.
(2013) - et al.
Pain conditions among veterans with schizophrenia or bipolar disorder
Gen. Hosp. Psychiatry
(2013) - et al.
Impact of comorbid migraine on the clinical course of bipolar disorder
Compr. Psychiatry
(2012) - et al.
Prevalence and clinical features associated to bipolar disorder–migraine comorbidity: a systematic review
Compr. Psychiatry
(2015) - et al.
Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: relationship with cyclothymic temperament and “therapeutic sensation seeking” in response towards subjective intolerance to pain
J. Affect. Disord.
(2013) - et al.
The impact of premenstrual dysphoric disorder among 92 bipolar patients
Eur. Psychiatry
(2010) - et al.
Rapid cycling as a feature of bipolar disorder and comorbid migraine
J. Affect. Disord.
(2015) - et al.
Course sequences in bipolar disorder: depressions preceding or following manias or hypomanias
J. Affect. Disord.
(2013) - et al.
Headache syndromes and psychiatric disorders: association and familial transmission
J. Psychiatr. Res.
(1993) - et al.
A pharmaco-epidemiological study of migraine and antidepressant medications: complete one year data from the Norwegian population
J. Affect. Disord.
(2011)
Ibn Imran׳s 10th century treatise on melancholy
J. Affect. Disord.
Bipolar disorders following initial depression: modeling predictive clinical factors
J. Affect. Disord.
Is headache related to asthma, hay fever, and chronic bronchitis? The head-hunt study
Headache
Ibn Sina (Avicenna) on pathogenesis of migraine compared with the recent theories
Headache
Criteria for the “soft” bipolar spectrum: treatment implications
Psychopharmacol. Bull.
Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition (DSM-IV)
Interictal and periictal headache in patients with epilepsy: migraine-triggered seizures or epilepsy-triggered headache?
Eur. J. Neurol.
Limitation of the application of fourfold table analysis to hospital data
Biom. Bull.
Hippocrates: the forefather of neurology
Neurol. Sci.
Comorbidity of migraine and major affective disorders
Neurology
Rapid cycling in bipolar disorder: a systematic review
J. Clin. Psychiatry
Meta-analysis in clinical trials
Control. Clin. Trials
Perinatal episodes across the mood disorder spectrum
JAMA Psychiatry
Migraine headache in affectively ill latino adults of mexican american origin is associated with bipolarity
Prim. Care Companion J. Clin. Psychiatry
Medicine and psychiatry in Western culture: ancient Greek myths and modern prejudices
Ann. Gen. Psychiatry
Corrigendum to “treatment adherence towards prescribed medications in bipolar-II acute depressed patients: relationship with cyclothymic temperament and “therapeutic sensation seeking” in response towards subjective intolerance to pain” [J. Affect. Disord. 151 (2) (November 2013), 596–604]
J. Affect. Disord.
Cited by (36)
Headache and Migraine
2022, Comprehensive Clinical Psychology, Second EditionRevisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidity
2021, Journal of Affective DisordersCitation Excerpt :These new findings are indicative of a higher clinical burden in patients with a BD-migraine phenotype, a notion that is consistent with previous reports (Gordon-Smith et al., 2015; Romo-Nava et al., 2020a). However, we did not find a difference in migraine rates between BD subtypes, or an association of migraine with suicidality or comorbid eating or substance use disorders, or cardiometabolic disorders (e.g., obesity), as previously reported (Fornaro et al., 2014; Fornaro and Stubbs, 2015; Streel et al., 2017). An increased health burden and comorbidity pattern in individuals with BD and migraine may compel them to access the healthcare system earlier as compared to those without migraine, possibly accounting for the younger age observed in this group (McIntyre et al., 2006).
Evidence of new-onset depression among persons with migraine after discontinuing antidepressants
2020, Psychiatry ResearchCyclothymic temperament: Associations with ADHD, other psychopathology, and medical morbidity in the general population
2020, Journal of Affective DisordersPsychopharmacology of headache and its psychiatric comorbidities
2019, Handbook of Clinical NeurologyEpidemiology of pain and relation to psychiatric disorders
2018, Progress in Neuro-Psychopharmacology and Biological PsychiatryCitation Excerpt :The lifetime prevalence of bipolar disorder ranges from 0.3% to 4% (Weissman et al., 1996; Merikangas et al., 2007). Individuals with depression frequently reported chronic pain (Fornaro and Stubbs, 2015; Birgenheir et al., 2013; Chaturvedi, 1987). Table 3 shows that depression is also common among individuals with specific chronic pain, such as musculoskeletal pain (de Heer et al., 2014), neck or back pain (Demyttenaere et al., 2007; Dersh et al., 2006; Ciaramella and Poli, 2015; McWilliams et al., 2004; Reme et al., 2011; von Korff et al., 2005), headache (McWilliams et al., 2004; Oedegaard et al., 2006; Saunders et al., 2008; Zwart et al., 2003), orofacial pain (Manfredini et al., 2010; Bertoli and de Leeuw, 2016; Velly et al., 2003), rheumatoid Arthritis (Arnold et al., 2006), fibromyalgia (Aguglia et al., 2011; Arnold et al., 2006; Raphael et al., 2006; Thieme et al., 2004; Uguz et al., 2010), arthritis (McWilliams et al., 2004; Murphy et al., 2012; Stang et al., 2006), chronic abdominal pain (de Heer et al., 2014) and pelvic pain (Carvalho et al., 2015; Clemens et al., 2008; Masheb et al., 2005; Riegel et al., 2014), and neuropathic pain (Berger et al., 2004; Berger et al., 2012; Gore et al., 2007; Yawn et al., 2009).